期刊文献+

Effects of Vascular Endothelial Cell Growth Factor on Fibrovascular Ingrowth into Rabbit's Hydroxyapatite Orbital Implant 被引量:3

Effects of Vascular Endothelial Cell Growth Factor on Fibrovascular Ingrowth into Rabbit's Hydroxyapatite Orbital Implant
下载PDF
导出
摘要 Summary: The effects of different concentrations of vascular endothelial cell growth factor (VEGF) on the fibrovascular ingrowth into rabbits hydroxyapatite orbital implant were investigated. Twelve New Zealand white rabbits were divided into 3 groups and received hydroxyapatite orbital implant surgery in their right eyes. Before and after the operation, the implants were treated with 10 ng/ml VEGF, 100 ng/ml VEGF, or normal saline as control group. The animals received technetium bones scan at 2, 4, and 6 weeks postoperatively. The mean radioactivity counts within region of interest (ROI) of the surgery eye (R) and the non-surgery eye (L) in the same animal were tested, and the R/L ratios were calculated. The implants were harvested at 6th weeks and examined histopathologically. The results showed that at second week, there was no significant difference in mean R/L ratios between VEGF group and control group (F=2.83, P=0.111); At 4th week (F=7.728, P=0.011) and 6th week (F=7.831, P=0.011) postoperatively, the mean ratios in VEGF groups were significantly higher than that in control group. At 6th week postoperatively, the fibrovascularization rates in VEGF groups were higher than in control group significantly (F=8.711, P=0.008). It was suggested that VEGF could promote the fibrovascular ingrowth into hydroxyapatite orbital implant, thus might shorten the time required for complete vascularization of the HA orbital implant. Summary: The effects of different concentrations of vascular endothelial cell growth factor (VEGF) on the fibrovascular ingrowth into rabbits hydroxyapatite orbital implant were investigated. Twelve New Zealand white rabbits were divided into 3 groups and received hydroxyapatite orbital implant surgery in their right eyes. Before and after the operation, the implants were treated with 10 ng/ml VEGF, 100 ng/ml VEGF, or normal saline as control group. The animals received technetium bones scan at 2, 4, and 6 weeks postoperatively. The mean radioactivity counts within region of interest (ROI) of the surgery eye (R) and the non-surgery eye (L) in the same animal were tested, and the R/L ratios were calculated. The implants were harvested at 6th weeks and examined histopathologically. The results showed that at second week, there was no significant difference in mean R/L ratios between VEGF group and control group (F=2.83, P=0.111); At 4th week (F=7.728, P=0.011) and 6th week (F=7.831, P=0.011) postoperatively, the mean ratios in VEGF groups were significantly higher than that in control group. At 6th week postoperatively, the fibrovascularization rates in VEGF groups were higher than in control group significantly (F=8.711, P=0.008). It was suggested that VEGF could promote the fibrovascular ingrowth into hydroxyapatite orbital implant, thus might shorten the time required for complete vascularization of the HA orbital implant.
出处 《Journal of Huazhong University of Science and Technology(Medical Sciences)》 SCIE CAS 2004年第3期286-288,共3页 华中科技大学学报(医学英德文版)
关键词 vascular endothelial cell growth factor HYDROXYAPATITE orbital implants VASCULARIZATION vascular endothelial cell growth factor hydroxyapatite orbital implants vascularization
  • 相关文献

参考文献10

  • 1Buettner,H,Bartley,G B.Tissue breakdown and exposure associated with orbital hydroxyapatite implants[].American Journal of Ophthalmology.1992
  • 2Shields,C L,Shields,J A,De,Potter,P.Problems with the hydroxyapatite orbital implant: implant[].Ophthalmic Plastic and Reconstructive Surgery.1996
  • 3Civelek A C,Pacheco E M,Natarajan T K et al.Quantitative measurement of vascularization and vascular ingrowth rate of coralline hydroxyapatite ocular implant by Tc-99m MDP bone imaging[].Clinical Nuclear Medicine.1995
  • 4Goldberg,R A,Holds,J B,Ebrahimpour,J.Exposed hydroxyapatite orbital implants: report of six cases[].Ophthalmology.1992
  • 5Ferrara,N,Davis-Smyth,T.The biology of vascular endothelial growth factor[].Endocrine Reviews.1997
  • 6Kim,I,Ryan,A M,Rohan,R.Constitutive expression of VEGF, VEGFR-1, and VEGFR-2 in normal eyes[].Investigative Ophthalmology.1999
  • 7Hobson,M I,Green,C J,Terenghi,G.VEGF enhances intraneural angiogenesis and improves nerve regeneration after axotomy[].Journal of Anatomy.2000
  • 8Amano,S,Roban,R,Kutoki,M.Requirement for vascular endothelial growth factor in wound-and inflammation-related corneal neovascularization[].Investigative Ophthalmology.1998
  • 9Kinghton,D R,Hunt,T K,Scheuenstuhl,H.Oxygen tension regulates the expression of angiogenesis factor by macrophages[].Science.1983
  • 10Pacheco E M,Civeled A C,Natarajan T K et al.Clinicopathological correlation of technetium bone scan in vascularization of hydroxyapatite implants.A primate model[].Archives of Ophthalmology.1997

同被引文献16

引证文献3

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部